Avadel Pharmaceuticals (AVDL) Net Cash Flow: 2015-2022
Historic Net Cash Flow for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2022 value amounting to $14.1 million.
- Avadel Pharmaceuticals' Net Cash Flow rose 296.65% to $14.1 million in Q4 2022 from the same period last year, while for Dec 2022 it was $23.9 million, marking a year-over-year increase of 218.98%. This contributed to the annual value of $20.8 million for FY2024, which is 148.17% up from last year.
- As of Q4 2022, Avadel Pharmaceuticals' Net Cash Flow stood at $14.1 million, which was up 119.56% from $6.4 million recorded in Q3 2022.
- In the past 5 years, Avadel Pharmaceuticals' Net Cash Flow registered a high of $63.8 million during Q1 2020, and its lowest value of -$28.2 million during Q2 2018.
- Over the past 3 years, Avadel Pharmaceuticals' median Net Cash Flow value was -$204,500 (recorded in 2022), while the average stood at $5.4 million.
- Within the past 5 years, the most significant YoY rise in Avadel Pharmaceuticals' Net Cash Flow was 23,015.94% (2020), while the steepest drop was 359.77% (2020).
- Avadel Pharmaceuticals' Net Cash Flow (Quarterly) stood at -$8.4 million in 2018, then soared by 62.79% to -$3.1 million in 2019, then slumped by 274.55% to -$11.7 million in 2020, then skyrocketed by 38.59% to -$7.2 million in 2021, then soared by 296.65% to $14.1 million in 2022.
- Its Net Cash Flow stands at $14.1 million for Q4 2022, versus $6.4 million for Q3 2022 and -$6.8 million for Q2 2022.